Grail sets out on its own on the public markets

The latest stories trending on MedCity News.

Editor's Pick

Top Story Illumina Spin-Off Now Complete, Grail Sets Out on Its Own on the Public Markets Liquid biopsy company Grail is now an independent, publicly traded company. While the separation from Illumina ends a protracted antitrust battle, Grail is still in the early stages of a long-term strategy to win regulatory validation and payor coverage for its multi-cancer early detection test. Sponsored Are GLP-1 Drugs Here to Stay? Presented by MedCity News & Abarca Health We recently spoke with Nicole Bulochnik, senior vice president of drug strategy for Abarca, about what payers need to consider as demand for this group of weight-loss drugs remains high.  Learn More. Explore the INVEST Digital Health 2024 Agenda Be part of the transformation shaping healthcare at INVEST Digital Health at Pegasus Park in Dallas on September 18. See the event Agenda featuring expert-led panels discussing the future of healthcare, AI, and investment. Our panels are designed to spark conversations and foster innovation in the healthcare industry. Secure Your Spot Today

Featured News

Streamlining the Patient Consent Process Velatura, a leading multi-jurisdictional health information exchange and health data utility, along with Docusign, the leading intelligent agreement management solution that accelerates the process of doing business, have joined forces to streamline the process of obtaining and managing informed patient consent. Meet The Startup That Gives Consumers Access to 100+ Lab Tests For $500 Per Year Function Health, a membership-based platform that gives consumers access to more than 100 different lab tests, closed a Series A financing round that brought its total funding to date to $53 million. The round was led by Andreessen Horowitz and included a slew of celebrity investors, including Matt Damon, Zac Efron, Blake Griffin and Colin Kaepernick. Pomelo Care Secures $46M To Increase Access to Maternal Health Pomelo Care's $46 million Series B funding round was led by existing investors First Round Capital and a16z and included participation from Stripes, Box Group, Operator Partners and SV Angel. Decoding the Digital Footprint of Healthcare Professionals: A Roadmap for Pharma Marketers Knowing where healthcare professionals are online, their preferred platforms, and what they do there is crucial for pharma marketers.

Resources

MedCity FemFwd: What Needs To Happen to Improve Preeclampsia Rates? In this episode, we're joined by John Auerbach, senior vice president of federal health at consulting firm ICF. He discusses rising preeclampsia rates and how stakeholders need to act. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe